Harnessing the power of genomic sequencing augments diagnosis and treatment of lymphoid cancer

A new study has established that hybrid-capture sequencing is the method of choice for sequencing ‘actionable’ gene mutations across the most common forms of lymphoid cancer. Due to its applicability in routinely acquired formalin-fixed, paraffin-embedded tissues, this assay can be implemented by clinical laboratories into routine diagnostic workflows. It reliably identifies potentially actionable gene mutations […]